Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viral Transfer Technology
  • Published:

Clinical retroviral vector production: step filtration using clinically approved filters improves titers

Abstract

Production of retroviral vectors for clinical use requires removal of cells and cellular debris. We combined a series of filters of decreasing pore size using commercially available blood banking filters approved for clinical use. The collection bag and filters can be connected to create a sterile, closed system using clinically approved tubing and sealing systems. Even when challenged with a large number of vector producer cells (2.38 × 109cells), no viable cells are passed through the system. The step filtration system developed minimizes the titer reduction associated with filtration, provides rapid flow rates, and was cost effective when filtering volumes in excess of 2 liters.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Reeves L, Smucker P, Cornetta K . Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience Hum Gene Ther 2000 11: 2093–2103

    Article  CAS  PubMed  Google Scholar 

  2. Le Doux JM, Morgan JR, Snow RG, Yarmush ML . Proteoglycans secreted by packaging cell lines inhibit retrovirus infection J Virol 1996 70: 6468–6473

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Braas G, Searle PF, Slater NKH, Lyddiatt A . Strategies for the isolation and purification of retroviral vectors for gene therapy Bioseparation 1996 6: 211–228

    CAS  PubMed  Google Scholar 

  4. Kotani H et al. Improved methods of retroviral vector transduction and production for gene therapy Hum Gene Ther 1994 5: 19–28

    Article  CAS  PubMed  Google Scholar 

  5. Bowles NE et al. A simple and efficient method for concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo Hum Gene Ther 1996 7: 1735–1742

    Article  CAS  PubMed  Google Scholar 

  6. McGrath M, Witte O, Pincus T, Weissman IL . Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity J Virol 1978 25: 923–927

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Lyddiatt A, O'Sullivan DA . Biochemical recovery and purification of gene therapy vectors Curr Opin Biotechnol 1998 9: 177–185

    Article  CAS  PubMed  Google Scholar 

  8. Hammar L . Concentration of biomaterials: virus concentration and viral protein isolation Meth Enzymol 1994 228: 640–658

    Article  CAS  Google Scholar 

  9. Cavazzana-Calvo M et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 2000 288: 669–672

    Article  CAS  PubMed  Google Scholar 

  10. Abonour R et al. Efficient retroviral-mediated MDR-1 gene transfer into autologous human long-term repopulating hematopoietic stem cells Nature Med 2000 6: 652–658

    Article  CAS  PubMed  Google Scholar 

  11. Miller AD et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus J Virol 1991 65: 2220–2224

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Miller AD, Buttimore C . Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production Mol Cell Biol 1986 6: 2895–2902

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Markowitz D, Goff S, Bank A . A safe packaging line for gene transfer: separating viral genes on two different plasmids J Virol 1988 62: 1120–1124

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Markowitz D, Goff S, Bank A . Construction and use of a safe and efficient amphotropic packaging line Virology 1988 167: 400–406

    Article  CAS  PubMed  Google Scholar 

  15. Bierhuizen MF et al. Enhanced gene fluorescent protein as selectable marker of retroviral-mediated gene transfer in immature hematopoietic bone marrow cells Blood 1997 90: 3304–3315

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to Dr Philip Maples for his technical advice in filter selection. We would like to thank Christine Starkey, Clara Hazelgrove and Lisa Woodsides for their technical contributions to this manuscript. The Indiana University Vector Production Facility is a NIH designated National Gene Vector Laboratory (U42 RR11148) and this work was supported in part by a Centers of Excellence in Molecular Hematology grant (PHS P50 DK49218) and a core laboratory supporting PHS P01 HL53586.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reeves, L., Cornetta, K. Clinical retroviral vector production: step filtration using clinically approved filters improves titers. Gene Ther 7, 1993–1998 (2000). https://doi.org/10.1038/sj.gt.3301328

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301328

Keywords

This article is cited by

Search

Quick links